PMID- 22919263 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240316 IS - 1071-2089 (Print) IS - 1751-9861 (Electronic) IS - 1071-2089 (Linking) VI - 16 IP - 3-4 DP - 2011 Dec 1 TI - USE OF THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE (MCID) FOR EVALUATING TREATMENT OUTCOMES WITH TMJMD PATIENTS: A PRELIMINARY STUDY(). PG - 148-166 AB - Temporomandibular joint and muscle disorder (TMJMD) is one of the most prevalent types of musculoskeletal disorders. The major goal of the study was to more objectively quantify clinically meaningful relief for TMJMD treatment outcomes by using the new metric of minimal clinically important difference (MCID). Pre- to post-treatment changes on a number of self-report measures were evaluated in a cohort of 101 acute TMJMD patients. An anchor-based MCID approach was employed, with an objective chewing performance measure serving as the clinical outcome of interest. Using a Receiver Operating Curve analysis, it was found that the Physical Component Scale (PCS) of the SF-36 was the most robust self-report measure to use as the MCID in a TMJMD patient population. FAU - Ingram, Megan AU - Ingram M FAU - Choi, Yun Hee AU - Choi YH FAU - Chiu, Chung-Yi AU - Chiu CY FAU - Haggard, Rob AU - Haggard R FAU - Dougall, Angela Liegey AU - Dougall AL FAU - Buschang, Peter AU - Buschang P FAU - Gatchel, Robert J AU - Gatchel RJ LA - eng GR - U01 DE010713/DE/NIDCR NIH HHS/United States PT - Journal Article DEP - 20120110 PL - United States TA - J Appl Biobehav Res JT - Journal of applied biobehavioral research JID - 9502505 PMC - PMC3423998 MID - NIHMS382775 EDAT- 2012/08/25 06:00 MHDA- 2012/08/25 06:01 PMCR- 2013/01/10 CRDT- 2012/08/25 06:00 PHST- 2012/08/25 06:00 [entrez] PHST- 2012/08/25 06:00 [pubmed] PHST- 2012/08/25 06:01 [medline] PHST- 2013/01/10 00:00 [pmc-release] AID - 10.1111/j.1751-9861.2011.00068.x [doi] PST - ppublish SO - J Appl Biobehav Res. 2011 Dec 1;16(3-4):148-166. doi: 10.1111/j.1751-9861.2011.00068.x. Epub 2012 Jan 10.